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Available online 14 May 2015Cardiomyocytes (CMs) derived from human induced pluripotent stem cells (hiPSCs) are being increasingly used
to model human heart diseases. hiPSC-CMs generated by earlier aggregation-based methods (i.e., embryoid
body) often lack functional sarcoplasmic reticulum (SR) Ca stores characteristic of mature mammalian CMs.
Newermonolayer-based cardiac differentiationmethods (i.e., Matrigel sandwich or small molecule-based differ-
entiation) produce hiPSC-CMs of high purity and yield, but their Ca handling has not been comprehensively
investigated. Here, we studied Ca handling and cytosolic Ca buffering properties of hiPSC-CMs generated inde-
pendently from multiple hiPSC lines at Stanford University, Vanderbilt University and University of Wisconsin-
Madison. hiPSC-CMs were cryopreserved at each university. Frozen aliquots were shipped, recovered from cryo-
preservation, plated at low density and compared 3–5 days after plating with acutely-isolated adult rabbit and
mouse ventricular CMs. Although hiPSC-CM cell volumewas signiﬁcantly smaller, cell capacitance to cell volume
ratio and cytoplasmic Ca bufferingwere not different from rabbit-CMs. hiPSC-CMs from all three laboratories ex-
hibited robust L-type Ca currents, twitch Ca transients and caffeine-releasable SR Ca stores comparable to adult
CMs. Ca transport by sarcoendoplasmic reticulum Ca ATPase (SERCA) and Na/Ca exchanger (NCX) was similar
in all hiPSC-CM lines, but slower compared to rabbit-CMs. However, the relative contribution of SERCA and
NCX to Ca transport of hiPSC-CMs was comparable to rabbit-CMs. Ca handling maturity of hiPSC-CMs increased
from 15 to 21 days post-induction. We conclude that hiPSC-CMs generated independently from multiple iPSC
lines using monolayer-based methods can be reproducibly recovered from cryopreservation and exhibit compa-
rable and functional SR Ca handling.
© 2015 The Authors. Published by Elsevier Ltd. This is an open access article under the CC BY-NC-ND license
(http://creativecommons.org/licenses/by-nc-nd/4.0/).1. Introduction
Ca signaling controls excitation–contraction coupling (ECC) in heart
muscle [1]. However, detailed mechanistic studies of human cardio-
myocyte (CM) Ca handling in both basic science and drug discovery
have been limited by lack of an appropriate human CMmodel. The use
of acutely-isolated primary human CMs is hampered by their rare avail-
ability and technical limitations. Coupled with increasing prevalence ofacology, Vanderbilt University
. 1265, 2215B Garland Ave,
fﬁce), +1 615 936 7303 (lab);
. Knollmann).
. This is an open access article underheart failure, lack of current therapies, rising drug attrition rates and car-
diac toxicity, there is a great need for in vitro human CM evaluation.
The recent establishment of human induced pluripotent stem cells
(hiPSCs) has provided a new approach for obtaining human CMs [2,3].
hiPSCs, generated from mature somatic cells harvested from patients,
are analogous to human embryonic stem cells (hESCs); while avoiding
the ethical controversies surrounding their use [4]. Hence, hiPSCs
represent a renewable cell source of patient- or disease-speciﬁc tis-
sue, potentially avoiding immune rejection [5]. Additionally, hiPSCs can
be differentiated to cells of all three germ layers, including cardiac meso-
derm [2] thus enabling generation of CMs from different genetic back-
grounds. Signiﬁcant progress has been made in hiPSC-CM cardiac
differentiation protocols, evolving from the inefﬁcient and variable
aggregation-based methods (i.e., embryoid body (EB)), to more robust
monolayer-based methods, such as the Matrigel sandwich and smallthe CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
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sarcomeric and Ca handling proteins, similar to native myocardium [7,
9]. hiPSC-CMs have been shown to recapitulate several inherited heart
disease phenotypes; thus representing a theoretically unlimited source
of CMs for experimental studies.
Inmature ventricular CMs, ECC is initiated bymembrane depolariza-
tion followed by inﬂux of Ca via L-type Ca channels. Entering Ca triggers
Ca-induced Ca release (CICR) from the sarcoplasmic reticulum (SR) via
ryanodine receptor Ca release channels [10]. The ensuing rise in intra-
cellular Ca binds to the troponin complex and activates myoﬁlament
contraction [11]. For relaxation to occur, Ca must be removed from the
cytoplasmby twoprimary removal pathways: the sarcoendoplasmic re-
ticulumCaATPase (SERCA) and theNa/Ca exchanger (NCX), with other,
non-NCX non-SR removal pathways such as plasma lemma Ca ATPase
and mitochondria contributing less than 5% [12]. Given Ca's central
role in linking electrical activation and contraction, dysfunctional CM
Ca handling has been associated with contractile dysfunction, arrhyth-
mia and other heart diseases [13,14].
Earlier studies of the functional properties of hiPSC-CMs have largely
focused on their electrophysiological properties. hiPSC-CMs have been
shown to express all ion channels naturally found in adult human left
ventricular tissue [15,16]. Additionally, hiPSC-CMs generated using the
monolayer Matrigel sandwich method display human-like action po-
tential morphology and robust L-type Ca currents [7]. However, their
Ca handling properties remain not well understood. To date, Ca
handling and SR function have only been investigated in hiPSC-CMs
generated by the EB method [15,17–19].
A major concern for use of hiPSC-CMs is their relatively “immature”
phenotype which may result in substantial differences in their physiol-
ogy when compared to native CMs. With respect to Ca handling, earlier
reports have indicated that hESC-CMs and hiPSC-CMs derived from EB-
based methods at times lack functional SR stores and depend primarily
on trans-sarcolemmal Ca entry for contraction [9–11]. The usefulness of
hiPSC-CMs depends, in part, on their contractile properties which in
turn relies on Ca handling of these cells [11].
Here, we compare cell volume and intracellular Ca handling proper-
ties of hiPSC-CMs generated frommultiple hiPSC lines independently by
three laboratories at three different institutions to that of acutely-
isolated adult rabbit and mouse ventricular CMs under identical exper-
imental conditions. To the best of our knowledge, this is the ﬁrst report
of a systematic evaluation of Ca handling in hiPSC-CMs derived by
monolayer based cardiac differentiation methods. We ﬁnd that hiPSC-
CMs from different laboratories exhibit comparable and reproducible
intracellular Ca handling parameters including robust and functional
SR Ca stores. We further ﬁnd that both cytosolic Ca buffering properties
and relative contribution of SR and sacolemmal transport pathways of
hiPSC-CMs are comparable to that of acutely-isolated rabbit CMs.
Taken together, our results suggest that hiPSC-CMs generated by
monolayer-based methods from multiple hiPSC lines can be reproduc-
ibly recovered from cryopreservation and exhibit relatively mature Ca
handling properties.
2. Material and methods
The University Committee on Use and Care of Animals at Vanderbilt
UniversityMedical Center approves all animal protocols. All animal pro-
tocols conformed to the Guiding Principles in the Care and Use of Animals
of theAmerican Physiological Society. Data averaged frommultiple days
were used for analysis. All procedures and data analysis were carried
out in blinded fashion regarding the experimental groups. All chemicals,
unless otherwise speciﬁed, were obtained from Sigma (St. Louis, MO).
2.1. Human iPSC Derivation and Culture
Human induced pluripotent stem cells (hiPSCs) from healthy volun-
teers were independently generated, as previously described, by threelaboratories Stanford University [20], Vanderbilt University [21], and
University of Wisconsin-Madison [7,22]. All protocols were approved
by the respective institutions Institutional ReviewBoard. Three different
methods of reprogramming were used. Brieﬂy, the Stanford hiPSC line,
13FLVN0C1, was derived from adult ﬁbroblast using lentivirus based
reprogramming [20]. The Vanderbilt hiPSC line, CC2, was derived from
dermal ﬁbroblast by non-integrating episomal based reprogramming
method [23]. The Wisconsin hiPSC line, DF19-9-11 T, was derived
from neonatal foreskin ﬁbroblast by vector and transgene free episomal
based reprogramming [22]. For all reprogramming individual colonies
with typical hESCmorphology were picked at day 17 to 30 and clonally
expanded. hiPSC lines were routinely maintained on Matrigel, growth
factor-reduced 1:200 (Corning) or on Synthemax II-SC coated plates
in mTeSR1 medium (Stemcell Technologies) or E8 medium (Stanford
University). Cells were passaged every 4 days using 0.5 mM EDTA
(Life Technologies) in D-PBS without CaCl2 or MgCl2 (Life Technolo-
gies). 2 μM thiazovivin (Selleck Chemicals) or 10 μM Rho kinase inhibi-
tor Y-27632 (CalBiochem) was added for the ﬁrst 24 h after passaging.
Cells were maintained at 37 °C, with 5% CO2 and 5% O2.
2.2. Monolayer-based cardiac differentiation
Two different protocols were used for induction of cardiac differen-
tiation at the three institutions, both protocols yield 80–95% troponin T
positive cells that spontaneously contract from day 7:
1. Matrigel Sandwich Induction (University of Wisconsin-Madison[7]&
Vanderbilt University[21]). Brieﬂy, hiPSCs (Np20) were incubated
with Versene solution (Invitrogen) (1 mL/well 6-well plate) at
37 °C for 5 minutes to dissociate cells. Cell were seeded on Matrigel
growth factor-reduced (Corning) coated plates at a density of
100,000 cells/cm2 in mTeSR1 medium (Stemcell Technologies) sup-
plemented with 10 μM Rho kinase inhibitor Y-27632 (CalBiochem).
The mTeSR1 medium was changed daily for 4 days at which point
the monolayer reached ~80% conﬂuence. A thin layer of Matrigel
0.5 mg was overlaid in ice-cold mTeSR1 medium. When cells
reached 100% conﬂuence, medium was changed to basal medium
RPMI 1640 (11875, Life Technologies) supplemented with B-27
without insulin (Invitrogen) containing Activin A (100 ng/mL, R&D
Systems) andMatrigel (0.5mgMatrigel/6-well plate) this is referred
to as day 0. On day 1 medium was changed to RPMI 1640 medium
plus B-27without insulin supplement (Invitrogen) withoutMatrigel
and supplemented with BMP4 (5–10 ng/mL, R&D Systems) and
(bFGF 5–10 ng/mL, Invitrogen) for 4 days. At day 5, RPMI 1640medi-
um plus B27 complete supplement (Invitrogen) was added and me-
dium changed every 3 days until dissociation.
2. Small Molecule Induction (Stanford University[8,24]). Brieﬂy, hiPSCs
(Np20) cultured in E8 medium were split at 1:12 ratio. Cells were
grown for 4 days at which time they reached ~80% conﬂuence. This
is referred to as day 0; medium was changed to cardiac differentia-
tion medium consisting of RPMI 1640 (11875, Life Technologies)
and B-27 minus insulin supplement (A1895601, Life Technologies)
supplemented with 10 μM CHIR99021 (LC Laboratories) for day 0
to day 1. On day 1 medium was changed to cardiac differentiation
medium. On day 3 medium was changed to cardiac differentiation
medium supplementedwith 5 μM IWR-1 (Sigma). On day 5medium
was changed to cardiac differentiation medium. Medium was
changed on day 7 to cardiac medium consisting of RPMI1640
(11875, Life Technologies) and B-27 supplement (17504, Life Tech-
nologies), and every other day until dissociation.
2.3. hiPSC-CM dissociation, storage and plating
hiPSC-CMs were incubated with TrypLE Express (Life Technologies)
for 10 min at 37 °C to dissociated cells. hiPSC-CMs were cryopreserved
in 10% DMSO, 90% FBS and stored in liquid nitrogen at days 15, 21,
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were thawed and plated at low density on Matrigel growth factor-
reduced coated dishes in solution containing: RPMI 1640 medium
(11875, Life Technologies), 2% B-27 supplement (Invitrogen), and 1%
Pen-Strep (Life Technologies). hiPSC-CMs were maintained at 5% CO2
and 21% O2. All experiments were performed 3–5 days after plating.
2.4. Primary myocyte isolation
Ventricular myocytes from mouse and rabbit were isolated by a
modiﬁed collagenase/protease method as previously described [25].
All the experiments conducted in Tyrode's solution containing (in
mM): CaCl2, NaCl 134, KCl 5.4, MgCl2 1, glucose 10, and HEPES 10, pH
adjusted to 7.4 with NaOH. Final concentration of Ca is 2 mM.
2.5. Measurement of cell volume
Tomeasure myocyte volume, Z-stacks were obtained using a confo-
cal microscope (LSM 510, 25× oil immersion Plan-Neoﬂuar lens) as de-
scribed in [26]. Brieﬂy, myocytes were loaded with Calcein AM (5 μM,
30 min; Molecular Probes, Eugene, OR) to label intracellular space.
Myocytes were washed twice to remove extracellular calcein. Calcein
ﬂuorescence was excited at 488-nm with 1% argon laser power. 25–46
images (1.5 μm sections) were obtained for each myocytes. Images
were reconstructed in 3D and surface area and volume analyzed using
the 3D image analysis program IMARIS (Bitplane, South Windsor, CT).
2.6. Measurement of Intracellular Ca
Myocytes were loaded with Fura-2 acetoxymethyl ester, Fura-2 AM
(Molecular Probes Inc., Eugene, OR) as described previously [25]. Brieﬂy,
myocytes were incubated with 2 μM Fura 2 AM for 8 min at room tem-
perature to load the indicator in the cytosol. Myocytes were washed
twice for 10 min with Tyrode's solution containing 250 μM probenecid
to retain the indicator in the cytosol. A minimum of 30 min were
allowed for de-esteriﬁcation before imaging the cells. Fura 2-AM loaded
myocyte Ca transients recorded during 0.5 Hz ﬁeld stimulation in 2mM
Ca Tyrode's solution for 20 s at room temperature. Then stimulationwas
switched off followed by application of caffeine 10 mM for 5 s to esti-
mate SR Ca content. A subset of cells were exposed to 0Ca0Na Tyrode's
solution for 10 s then caffeine 10 mM applied for 30 s to estimate non-
NCX Ca extrusion. For each cell and each experimental condition, tau
(τ), amplitude and baseline values were averaged from 3 consecutive
Ca transients. Ca transients were recorded and analyzed using commer-
cially available data analysis software (IonOptix, IonWizardTM Milton,
MA). All experiments were conducted at room temperature.
2.7. Ca buffering measurements
To measure cytosolic Ca buffering, we used the “Trafford” method
[27], as described in detail in [28]. Brieﬂy, myocytes were loaded with
25 μM Fluo-4 salt into pipette solution to measure cytosolic Ca. Caffeine
(10 mM) was rapidly applied to release Ca from the SR, which then ex-
truded via the Na/Ca exchanger (NCX), generating an inward NCX cur-
rent. Integration of NCX current yielded the total amount of Ca released
from the SR. To calculate Ca concentration, cell volume was estimated
from the cell capacitance using the published conversion factor of
4.58 pF/pL for rabbit CM. The conversion factor of 4.57 pF/pL for
hiPSC-CM was calculated from the average hiPSC-CM volume of based
on the measured average hiPSC-CM volume of 3.96 ± 0.25 pL (Fig. 1)
and average hiPSC-CM capacitance of 18.1 ± 1.4 pF. Then Δ[Ca]total
was plotted as a function of Δ[Ca]free and maximal cytosolic buffering
capacity (Bmax) and dissociation constant (Kd) calculated. For consisten-
cy, cellular Ca is represented in units of μmol/Lcytosol, excluding mito-
chondrial contribution [29].2.8. Measurements of L-type Ca current
Mouse-CM and iPSC-CMs were studied using whole-cell patch
clamp technique. External solution contained (in mM): NaCl 134, CsCl
5, MgCl2 1, CaCl2 2, glucose 10, HEPES 10, adjusted to pH 7.4 with
NaOH. The pipette solution contained (in mM): CsCl 110, MgCl2 1,
MgATP 5, cAMP 0.2; EGTA 14; Hepes 20; adjusted to pH = 7.25 with
CsOH. Currents were elicited by 200-ms depolarizing steps ranging
from−40 mV to +40 mV (with 10 mV increment), from holding po-
tential of−70mV. A 20-ms conditioning pulse to−40mVwas applied
prior to test pulse to inactivate Na currents. All experiments were
carried out at room temperature.
2.9. Calculation of Ca ﬂux balance
The decay rates of Ca transients in different extracellular solutions
were used to calculate relative contribution of Ca removal pathways
during relaxation inmyocytes [29]. Brieﬂy, total Ca removal from the cy-
tosol was estimated by the rate constant of ﬁeld-stimulated twitch Ca
transients (τtwitch). The rate constant of caffeine-induced Ca transient
(τCaff) represents non-SR Ca removal pathways (caffeine opens SR Ca
release channels and prevents SR Ca uptake), which in cardiomyocytes
is primarily the NCX. The rate constant of caffeine-induced Ca transient
in Na and Ca-free solutions (τCaff0Na), which blocks the NCX, measures
non-NCX non SR-mediated Ca removal. The relative contribution of
each Ca ﬂux pathway was calculated from removal time constant τ
(s) of Ca transients for the three different conditions, with the following
equations:
1=τtwitch ¼ KSERCA þ KNCX þ Knon−NCX ð1Þ
1=τCaff ¼ KNCX þ Knon−NCX ð2Þ
1=τCaff0Na ¼ Knon−NCX: ð3Þ
KSERCA,KNCX andKnon-NCX represent the rates of Cauptake into the SR,
NCX-mediated removal and non-NCX non-SR mediated removal,
respectively.
2.10. Statistical analysis
Differences among the groupswere assessed using one-way ANOVA.
Results were considered statistically signiﬁcant if the p-value was less
than 0.05 adjusted by Bonferroni correction for multiple comparisons.
3. Results
3.1. Cell morphometry and Ca handling of hiPSC-CMs and adult ventricular
animal-CMs
Single hiPSC-CMs at age 21 days post induction were plated at low
density on Matrigel coated dishes and cell surface area, cell volume
and Ca handling measured 3–5 days after plating. Protein expression,
CM purity, and electrophysiological characterization of the hiPSC-CMs
used in our experiments have been reported elsewhere [7,8,21] and
are not investigated here. We ﬁrst measured myocyte shape and vol-
ume from Z-stacks of confocal images after loading cells with calcein
to label intracellular space [26]. The shape of hiPSC-CM was highly var-
iables, ranging from circular to elongated to triangular morphology
(Fig. 1A). hiPSC-CMs were much smaller (cell volume 3.96 ± 0.25 pL,
n = 44) compared to adult mouse ventricular CM (cell volume 29 ±
2 pL, n = 34). On the other hand, cell surface area to volume ratio was
signiﬁcantly larger in hiPSC compared to mouse CM (Fig. 1B). Circular
hiPSC-CM had lower surface area and volume compared to elongated
and triangular iPSC-CM, but surface to volume ratio was not statistically
different among the three hiPSC-CM cell shapes (Fig. 1B).
Fig. 1. Surface area and volume of mouse-CM and hiPSC-CMs. A, representative examples of three-dimensional reconstruction of mouse-CM and hiPSC-CMs. B, averaged data. Values are
mean ± SEM. N = 13-34 per group. ***P b 0.001 vs mouse-CM.
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low-afﬁnity Ca sensitive indicator Mag Fluo-4 demonstrates that both
hiPSC-CMs and adult mouse-CMs have robust intracellular Ca stores
(Fig. 2A). We next compared the Ca handling of ﬁeld-stimulated
(0.5Hz) hiPSC-CMs to that of adult primary ventricular rabbit and
mouse CMs under identical experimental conditions. Typical Ca han-
dling parameters (diastolic [Ca], Ca transient amplitude, time to peak,
Ca decay rate) were not signiﬁcantly different among all three hiPSC-
CM lines. Compared to adult rabbit and mouse CMs, only time to peak
and Ca transient decay rates were signiﬁcantly slower in hiPSC-CM,
whereas all other Ca handling parameters were not different (Fig. 2).
We next tested for the presence of functional sarcoplasmic reticulum
(SR) Ca stores using caffeine, an agonist of ryanodine receptor (RyR2) Ca
release channels. Analogous to adult primary CMs, all hiPSC-CMs tested
exhibited robust caffeine-releasable SR Ca stores (Fig. 2 B&C). Caffeine-
induced Ca transients and hence SR Ca contentwere of similarmagnitude
and not signiﬁcantly different from rabbit or mouse-CMs. These results
are consistent with the presence of intracellular Ca stores stained with
Mag Fluo-4 (Fig. 2A) Taken together; these data demonstrate that single
hiPSC-CMs exhibit intracellular Ca transients comparable to that of adult
animal-CMs, and that the presence of functional SR in hiPSC-CMs derived
using monolayer-based methods is consistent across multiple labs.3.2. Cytoplasmic Ca buffering characteristics of hiPSC-CMs and rabbit-CMs
Using the height of the caffeine-induced Ca transient (Fig. 2) asmea-
sure of SR Ca content assumes that cytoplasmic buffering is unchanged;
an assumption that may not be correct because hiPSC-CMs display
disorganized contractile ﬁlaments [18] and Ca binding to myoﬁlaments
accounts for a large proportion of cytosolic Ca buffering [29]. Neverthe-
less, hiPSC-CMs studied here exhibit robust expression of myoﬁlament
proteins, including troponin C [16], the latter being the functionally
most important cytosolic Ca buffering site during physiological ECC[29]. Hence, we measured the cytoplasmic Ca buffering capacity of
hiPSC-CMs using the Trafford method (Fig. 3A). Although hiPSC-CMs
were signiﬁcantly smaller than rabbit-CMs (cell capacitance 18 ± 1 pF
vs 101 ± 12 pF, p b 0.01), the average cell capacitance to cell volume
ratio of hiPSC-CM was 4.46 pF/pL, a value that is very close to the pub-
lished value for rabbit ventricular myocytes (4.47 pF/pL) [26]. Maximal
binding capacity Bmax, which is an estimate of the total cytoplasmic Ca
binding sites, was not signiﬁcantly different between hiPSC-CMs and
rabbit CMs (Fig. 3B, top panel). Likewise, the apparent dissociation con-
stant Kd, an estimate of the cytosolic Ca binding afﬁnity, was not signif-
icantly different between hiPSC-CMs and rabbit-CMs (Fig. 3B, lower
panel). These results demonstrate that multiple hiPSC-CM lines have
comparable cytosolic Ca buffering properties which are comparable to
those of acutely-isolated rabbit-CMs.3.3. Characterization of Ca ﬂuxes in hiPSC-CMs
During each contraction-relaxation cycle, Ca enters the cytosol via L-
type Ca channels and via Ca-induced Ca release from SR Ca stores. Con-
sistentwith their robust twitch Ca transients (Fig. 2), all three hiPSC-CM
lines exhibit robust L-type Ca currents that were not statistically differ-
ent from L-type Ca currentmeasured inmouse CM (Fig. 4). Cytoplasmic
Ca removal ismediated by threemajor pathways: (1) Ca uptake into the
SR by the sarcoendoplasmic reticulum Ca ATPase (SERCA), (2) Ca efﬂux
from the cell via the NCX, and (3), non-NCX non-SRmediated pathways
such as plasma lemma Ca ATPase and mitochondria [25,29]. The contri-
bution of the individual Ca removal mechanisms has been studied
extensively in non-human CMs [30,31] but not yet in hiPSC-CMs. SR-
independent Ca removal was tested by rapid caffeine application and
was signiﬁcantly slower in hiPSC-CMs compared to rabbit and mouse
CMs (Fig. 5A). Block of NCX by 0Na 0Ca abolished the differences
between hiPSC-CMs and animal CMs (Fig. 5B), suggesting that NCX-
mediated Ca transport was responsible for the difference. We next
Fig. 2. Ca handling of hiPSC-CMs and animal CMs. A, confocal images of a mouse-CMs and hiPSC-CMs loaded with low-afﬁnity Ca indicator, Mag-Fluo-4 AM 5 μM to label intracellular Ca
stores (i.e. SR). B-C, representative Ca transients (B) and averaged data (C) recorded in hiPSC-CMs and acutely isolated adult ventricular rabbit andmouse CMs. Cells were ﬁeld-stimulated
(0.5 Hz, 20 s train) in 2mMCa Tyrode's solution followed by caffeine spritz (10mM, 5 s) to estimate SR Ca content. Values aremean± SEM. N= 22-27 per group. *P b 0.05 vs. hiPSC-CM.
(hiPSC-CM images (A) and example Ca transient records (B) shown are from Vanderbilt hiPSC-CMs).
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SERCA, NCX and non-NCX. Compared to rabbit-CMs, Ca ﬂux via SERCA
was signiﬁcantly slower in the hiPSC-CMs, and signiﬁcantly faster in
mouse-CMs (Supplemental Table 1). NCX Ca transport was also slower
in hiPSC-CMs compared to mouse and rabbit CMs, whereas non NCX Ca
removal was similar in all groups (Supplemental Table 1).
Next, we calculated the relative contribution of the Ca removal path-
ways from the individual decay rate constants listed in Supplemental
Table 1. Relative contribution of the three Ca transport systems
(SERCA, NCX, non-NCX) was comparable in all three hiPSC-CM lines
(Fig. 6). Furthermore, contribution of SERCA (61%) and NCX (31%) in
hiPSC-CMs was not signiﬁcantly different from adult rabbit-CMs
(SERCA 60%, NCX 32%). As expected [29,30], SERCA (89%) dominated
in mouse-CMs. On the other hand, the relative contribution of non-
NCX removal pathways was signiﬁcantly larger in hiPSC-CMs (8–9%)
compared to rabbit-CMs (4%) and mouse-CMs (2%).
3.4. Maturation of hiPSC-CMs Ca handling
Time in culture greatly affects molecular proﬁle, morphology and
function of hiPSC-CMs [32]. However, the time dependence of Ca han-
dling maturation has not been studied. Hence, we examined Ca han-
dling at three times after induction of cardiac differentiation (day 15,
21, and 30). Day 15 hiPSC-CMs exhibited signiﬁcantly smaller Ca twitch
transients (Fratio, τtwitch, day 15, 0.27 ± 0.07*; day 21, 0.40 ± 0.09; day
30, 0.41±0.07, *P b 0.05 vs day 21) and ~40% lower SR Ca content com-
pared to day 21 hiPSC-CMs (Fig. 7A). No further changes were observedin day 30 hiPSC-CM. Next, we investigated the time dependence of
changes in Caﬂuxpathways inmore detail. The average decay time con-
stants of Ca twitch transients (τtwitch) was signiﬁcantly slower in day 15
hiPSC-CMs comparedwith that of day 21 or day 30 hiPSC-CMs (Fig. 7B).
Likewise, caffeine-induced Ca transients were also signiﬁcantly slower
in day 15 hiPSC-CMs compared with that of day 21 or day 30 (τCaff
(s): day 15, 5.0 ± 0.4*; day 21, 2.9 ± 0.4; day 30, 3.0 ± 0.2, *P b 0.05).
However, non-NCX and non-SR mediated Ca removal time constants
were not affected by longer time in culture after cardiac induction
(τCaff0Na (s): day 15, 14.9 ± 1.7; day 21, 14.3 ± 2.1; day 30, 12.9 ±
0.8). These data demonstrate that the absolute rates of Ca transport
via SERCA and NCX signiﬁcantly increase between day 15 and day 21
hiPSC-CMs, whereas Ca ﬂuxes via non-SR and non-NCXmechanisms re-
main relatively constant. As a result, the relative contribution of Ca ﬂux
pathways shifts to predominantly SERCA and NCX (Fig. 7C), as seen in
adult rabbit CMs (Fig. 6). Hence, relativity mature Ca handling proper-
ties are reached as early as day 21 post cardiac differentiation.
To evaluate the reproducibility of hiPSC-CMs Ca handling measure-
ments, we quantiﬁed Ca ﬂux parameters in hiPSC-CMs (21 days post
cardiac induction) from the same cryopreserved batch that were plated
on different days. The average decay rates of twitch and caffeine-
induced Ca transients were not signiﬁcantly different between two in-
dependent plating for all three hiPSC-CM lines (Fig. 8A). Furthermore,
the relative contribution of Ca transport pathways was almost identical
in each batch (Fig. 8B). These results demonstrate that intracellular Ca
handling measurements are consistent and reproducible across multi-
ple independently generated hiPSC-CM lines.
Fig. 3. Cytoplamic Ca buffering properties of hiPSC-CMs and rabbit-CMs. A, representative cytoplasmic buffering curves generated using the Trafford method by plotting cytosolic [Ca]free
against the change in total cytoplasmic Ca concentration (Δ[Ca]total) derived from the NCX current integral during caffeine spritz to release SR Ca in hiPSC-CMs (example trace from
Stanford hiPSC-CM) and rabbit-CMs. B, averaged data. Values are mean ± SEM. N = 9–12 per group.
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4.1. Ca handling of hiPSC-CMs
Our report is theﬁrst study that systematically quantiﬁes Caﬂuxes in
hiPSC-CMs. Major new ﬁndings are that hiPSC-CMs generated by theFig. 4. L-typeCa currents of hiPSC-CMandmouse-CM.A, C, representative example of Ca currents fr
B, D current–voltage relationships of peak Ca currents from hiPSC-CM (Stanford, light gray, n = 6;latest monolayer based cardiac differentiation protocols exhibit robust
and functional SR Ca handling, and that the relative contribution of SR
Ca ﬂux (60%) in hiPSC-CMs is not statistically different from that of
acutely-isolated adult rabbit ventricular CMs (Fig. 6). Moreover, we have
for the ﬁrst time quantiﬁed cytosolic Ca buffering in hiPSC-CMs, which is
comparable to that of rabbit-CMs (Fig. 3). The latter result is of criticalomhiPSC-CM(Stanford,A) andmouse-CM(B). Voltageprotocol shownbelowcurrent records.
Vanderbilt, gray, n = 6;Wisconsin, black, n = 5) and frommouse CM (n= 6), respectively.
Fig. 5.Measurement of NCX and non-NCX Ca efﬂux. A, hiPSC-CM (example trace from Wisconsin hiPSC-CM) and animal CMs were exposed to Tyrode's solutions containing 10 mM
caffeine to measure combined NCX and non-NCX mediated Ca efﬂux. B, to measure only non-NCX-mediated Ca efﬂux, CMs were exposed to Tyrode's solution lacking Na and Ca. The
Ca transient decay rate (τ) was calculated for each cell and averaged for each group. N = 10-17 per group. *P b 0.05 vs. animal-CMs.
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indicators in CMs [33], an approach that is widely used for measuring Ca
transients and SR Ca content. Finally, our results demonstrate that inde-
pendently generated hiPSC-CM lines from healthy donors exhibit compa-
rable and reproducible Ca handling and cytosolic Ca buffering properties.
Previous studies of hESC-CMs and hiPSC-CMs generated by
aggregation-basedmethods (e.g., EBmethod) reported either a complete
lack of caffeine-releasable SR Ca stores [9] or their presence only in a sub-
population of CMs [18,19,34,35]. One study ﬁnds hiPSC-CMs Ca handling
relatively immature compared to hESC-CMs. In contrast, we ﬁnd
caffeine-release Ca stores in essentially 100% of hiPSC-CMs tested,Fig. 6. Relative contribution of Ca ﬂux pathways in different CMs. KSERCA, KNCX, and Knon-NCX wer
sients (see Supplemental Table 1). The individual rate constants were normalized by total ﬂux r
lines, rabbit-CMs and mouse-CMs.which is the same as in acutely-isolated adult CMs. The reasons for
these differences are unclear, but could be due to cardiac differentiation
variability, dependence on chemically undeﬁned growth factors and cy-
tokines, or growth factors and cytokines failing to gain access to the EB
interior. Given that the two monolayer approaches of cardiac induction
used here are standardized and published, and that Ca handling param-
eters at 21 days post induction (Fig. 2) was comparable among hiPSC-
CMs generated independently in difference labs, these two monolayer
methodsmay be preferable for future studies using hiPSC-CMs as cardiac
disease models. A recent report also characterized Ca handling of hiPSC-
CMs generated by monolayer-based Matrigel Sandwich method [36].e calculated from rate constants of decay of ﬁeld-stimulated and caffeine-induced Ca tran-
ate (Ktwitch), yielding the relative contribution of Ca ﬂux pathways for the three hiPSC-CM
Fig. 7.Maturation of Ca handling in hiPSC-CMs. A–B, representative Ca transients (A), and average data (B) of ﬁeld-stimulated (τtwitch) and caffeine-induced Ca transients (τCaff, τCaff0Na) at
day 15, 21, and 30 after hiPSC-CM induction. Data are from hiPSC-CMs generated at the University ofWisconsin. C, relative contribution of Ca ﬂuxes calculated as in Fig. 5. N= 13–22 per
group. *P b 0.05 vs. 15 days.
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gy in response to different pacing rates, while SR function and Ca ﬂuxes
were not evaluated. Furthermore, Ca ﬂuorescence measurements were
obtained from clumps or clusters of cells, not single cells as in our
study. These cases highlight the discrepancies in the ﬁeld, the need for
proper Ca handling controls, and consistent experimental design to com-
pare results.Fig. 8. Reproducibility of Ca handling parameters in hiPSC-CMs. A, average data of ﬁeld-stim
platings of each hiPSC-CM line. Values are mean ± SEM, N = 13–22 per group. B, relative con4.2. Comparison of hiPSC-CMs and acutely-isolated adult CMs
Lacking access to acutely-isolated healthy human ventricular CMs –
a common problem for the ﬁeld –we compared hiPSC-CMs with rabbit
and mouse CMs. Ca handling of rabbit-CMs are thought to be similar to
that of human ventricular CMs and have been widely used to model
human heart diseases [10]. We found that hiPSC-CMs have twitchulated (τtwitch) and caffeine-induced Ca transients (τCaff, τCaff0Na) from two independent
tribution of Ca ﬂuxes calculated as in Fig. 5.
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parable to that of rabbit-CMs. This contrasts with previous reports indi-
cating that hiPSC-CMs have smaller relatively “immature” Ca transients
[11]. On the other hand, two main differences exist between hiPSC and
rabbit CM Ca handling: 1) signiﬁcantly slower SERCA andNCX Ca trans-
port (Supplemental Table 1) and 2) slower time to peak Ca transient
(Fig. 2). Factors such as the lack of t-tubules of hiPSC-CMs leading to
an inefﬁcient Ca induced Ca release and hence impaired Ca-dependent
inhibition of L-type Ca current during the action potential plateau may
contribute to the slower time to peak of hiPSC-CM Ca transients.
While the differences in SERCA and NCX function could be due to spe-
cies differences between human and rabbits, a more likely explanation
is that Ca transport remains somewhat immature in hiPSC-CMs com-
pared to adult CMs. It will be interesting to study Ca ﬂuxes in hiPSC-
CMs generated using approaches that reportedly increase hiPSC-CM
maturity (e.g., 2D patterning [37], electrical stimulation [38], 3D culture
methods [39]). For example, Rao et al. reported a faster time to peak and
better SR function of hiPSC-CMs cultured onmicrogrooved compared to
unstructured polydimethylsiloxane membranes [37].
4.3. Maturation hiPSC-CM Ca handling
Although hiPSC-CMs beat as early as day 7 after cardiac induction,
signiﬁcant changes occur as the hiPSC-CMs continue to develop. For
example, hiPSC-CMs day 10 to 15 post-inductionwere shown to exhibit
decreased contractile response compared to older hiPSC-CMs [40].
Therefore, we investigated Ca handling at day 15, 21, and 30 after cardi-
ac induction.We found that day 15 hiPSC-CMs exhibit decreased twitch
Ca transients and SR Ca stores compared to day 21 hiPSC-CMs. Interest-
ingly, hiPSC-CMs did not continue tomature their Ca handling from day
21 to 30 (Fig. 7A). The ﬂux balance analysis showed a temporal transi-
tion of Ca ﬂux contributions from day 15 to day 21, with SERCA and
NCX contribution remaining similar, while non-NCX contribution is
decreased in day 21 hiPSC-CMs. These results suggest that non-NCX
pathways may be compensating for the decreased SECA activity in
early stage hiPSC-CMs. An earlier study [34] reported that NCX is largely
responsible for maintaining Ca homeostasis in hESC-CMs and that
genetic transfermay be necessary to increase SERCA contribution. How-
ever, our results demonstrate that in hiPSC-CMs this is not the case.
4.4. Implications for future hiPSC studies
The results of our experiments have a number of implications for
using hiPSC-CMs as experimental models. (1) hiPSC-CMs should be
allowed to mature in culture for at least 21 days instead of using when
the initially start beating [34,41]. (2) To reduce variability of the results,
hiPSC should be studied at a narrow and deﬁned time window after in-
duction instead of the wide windows of day 7–50 utilized previously
[41]. (3) Monolayer-based methods of cardiac differentiation are capa-
ble of generating hiPSC-CM with robust and functional SR Ca stores.
(4) Our experimental results provide a foundation for future disease
modeling studies by elucidating what “normal” hiPSC-CM Ca handling
is in vitro. (5) hiPSC-CMs can be reproducibly recovered from cryopres-
ervation demonstrating that these cells exhibit robust reproducible
properties especially with regard to Ca cycling. (6) hiPSC-CMs made
from different hiPSC lines that were derived from different tissue
sources by different methods of reprogramming have comparable
Ca handling. This result is reassuring, since there is concern in the
ﬁeld that starting cell source, e.g. neonatal or adult ﬁbroblast, and
reprogramming methodology, e.g. lentivirus- or episomal-based may
impact differentiated cell progeny, e.g. alter ECC, our result demonstrate
starting somatic cell source does not clearly impact functional readout.
Further, reprogramming methodology also does not obviously impact
progeny function.We show here in a direct comparison under identical
experimental conditions that hiPSC-CMs from fully reprogrammedhiPSCs using different cell sources and reprogramming methodologies
by different laboratories yield comparable results.
Finally, the methods of cryopreservation and recovery described
here could serve as a ﬁrst step of standardization,which is greatly need-
ed in the ﬁeld. Having frozen stocks of hiPSC-CM that can be reproduc-
ibly recovered as shown here opens up a number of possibilities. Cells
can be shared between labs, saved for future experiments, or for doing
larger experiments such as screening compound libraries.4.5. Limitations
Our study has several limitations. To ensure identical study condi-
tions, all hiPSC-CMs were frozen at speciﬁc dates after cardiac differen-
tiation, then thawed and re-plated prior to study. We cannot exclude
that the freezing and thawing process has altered the phenotype of
the hiPSC-CMs. However, the advantage of this approach is that multi-
ple batches of re-plated cells from different labs can be readily com-
pared, which is why we chose this approach here. This is also the
reason why we could not examine hiPSC-CMs older than 30 days, be-
cause the viability of older cells decreases substantially after freezing.
Another limitation is that we did not differentiate hiPSC-CM subtype
(i.e., nodal, atrial, and ventricular-like). However, previous studies
have shown that the cardiac induction protocols used here produce
approximately 80% ventricular-like CMs. Importantly, the cell to cell
variability of Ca handling parameters (i.e., twitch transient amplitude)
of hiPSC-CMs was comparable to that of acutely-isolated adult CMs
(approximately a 30% coefﬁcient of variation, see Fig. 2). Finally, we
did not tested whether our hiPSC-CMs also have prominent inositol tri-
phosphate (IP3) sensitive intracellular Ca stores as previously reported
for hESC-CMs. These Ca stores are not thought to play a role in healthy
adult ventricular CMs physiology however they can be upregulated in
diseased myocytes [42]. Future studies will have to determine if IP3 Ca
stores are present, and what effects if any they have on steady-state
Ca handling in hiPSC-CMs derived from healthy volunteers.Funding
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